These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 29019573)

  • 41. Double-blind trial of the use of transfer factor in the treatment of Crohn's disease.
    Vicary FR; Chambers JD; Dhillon P
    Gut; 1979 May; 20(5):408-13. PubMed ID: 381124
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Changes in T-lymphocyte response under the action of transfer factor in vivo].
    Buc M; Siska P; Rovenský J; Pruzinec P; Stefanovic J; Pekárek J; Svejcar J
    Bratisl Lek Listy; 1982 Jul; 78(1):63-73. PubMed ID: 6751474
    [No Abstract]   [Full Text] [Related]  

  • 43. Cell-mediated immunity and transfer factor in Crohn's disease.
    Ng RP; Vicary FR
    Br Med J; 1976 Jul; 2(6027):87-8. PubMed ID: 1084205
    [No Abstract]   [Full Text] [Related]  

  • 44. Primary brain tumors treated with steroids and radiotherapy: low CD4 counts and risk of infection.
    Hughes MA; Parisi M; Grossman S; Kleinberg L
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1423-6. PubMed ID: 16029802
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Augmentation of skin test reactivity and lymphocyte blastogenesis in patients with AIDS treated with transfer factor.
    Carey JT; Lederman MM; Toossi Z; Edmonds K; Hodder S; Calabrese LH; Proffitt MR; Johnson CE; Ellner JJ
    JAMA; 1987 Feb; 257(5):651-5. PubMed ID: 2432287
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of in vitro produced transfer factor on the immune response of cancer patients.
    Pizza G; Viza D; Boucheix C; Corrado F
    Eur J Cancer (1965); 1977 Sep; 13(9):917-23. PubMed ID: 578792
    [No Abstract]   [Full Text] [Related]  

  • 47. Adjuvant therapy for nonmetastatic osteogenic sarcoma: an evaluation of transfer factor versus combination chemotherapy.
    Gilchrist GS; Ivins JC; Ritts RE; Pritchard DJ; Taylor WF; Edmonson JM
    Cancer Treat Rep; 1978 Feb; 62(2):289-94. PubMed ID: 346219
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Transfer factor and its signification for practice.
    Mrázová A; Mráz J
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1993; 36(3):117-37. PubMed ID: 8159909
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transfer factor therapy in multiple sclerosis: a three-year prospective double-blind clinical trial.
    Van Haver H; Lissoir F; Droissart C; Ketelaer P; Van Hees J; Theys P; Vervliet G; Claeys H; Gautama K; Vermylen C
    Neurology; 1986 Oct; 36(10):1399-402. PubMed ID: 3093918
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transfer factor in the treatment of herpes simplex types 1 and 2.
    Khan A; Hansen B; Hill NO; Loeb E; Pardue AS; Hill JM
    Dermatologica; 1981; 163(2):177-85. PubMed ID: 6974662
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Restoration of immune system function is accelerated in immunocompromised mice by the B-cell-tropic isoxazole R-11.
    Zimecki M; Artym J; Kocięba M; Obmińska-Mrukowicz B; Mączyński M; Ryng S
    Pharmacol Rep; 2012; 64(2):403-11. PubMed ID: 22661192
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transfer-factor therapy of malignancy.
    Neidhart JA; LoBuglio AF
    Semin Oncol; 1974 Dec; 1(4):379-85. PubMed ID: 4220127
    [No Abstract]   [Full Text] [Related]  

  • 53. [Lymphocyte apoptosis in atopic dermatitis treated with transfer factor].
    García Angeles J; Flores Sandoval G; Orea Solano M; Serrano E; Estrada Parra S
    Rev Alerg Mex; 2003; 50(1):3-7. PubMed ID: 12822541
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Passive transfer of immunity in human Schistosomiasis mansoni: effect of transfer factor on early established infections.
    Warren KS; Cook JA; David JR; Jordan P
    Trans R Soc Trop Med Hyg; 1975; 69(5-6):488-93. PubMed ID: 1228987
    [No Abstract]   [Full Text] [Related]  

  • 55. [Personal experience with treatment of recurrent herpes infections using combined nonspecific immunostimulation].
    Bystron J; Bohác S; Braunová J; Koukalová D
    Cas Lek Cesk; 1992 Mar; 131(5):137-41. PubMed ID: 1316234
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lymphocyte marker testing in relation to the clinical use of dialyzed leukocyte extract containing transfer factor (DLE-LTF).
    Peetoom F; Florey MJ
    Haematologia (Budap); 1980; 13(1-4):225-37. PubMed ID: 7250812
    [No Abstract]   [Full Text] [Related]  

  • 57. The immunocompromised adult patient and surgery.
    Littlewood KE
    Best Pract Res Clin Anaesthesiol; 2008 Sep; 22(3):585-609. PubMed ID: 18831305
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A preliminary report on three AIDS Patients treated with anti-HIV specific transfer factor.
    Viza D; Lefesvre A; Patrasco M; Phillips J; Hebbrecht N; Laumond G; Vich JM
    J Exp Pathol; 1987; 3(4):653-9. PubMed ID: 3454809
    [No Abstract]   [Full Text] [Related]  

  • 59. Long-term transfer factor treatment in severe atopic dermatitis.
    Thulin H; Ellegaard J; Thestrup-Pedersen K; Zachariae H
    Acta Allergol; 1977 Aug; 32(4):236-7. PubMed ID: 578361
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Increase in E-rosettes after transfer factor (TF) treatment: fractionation of TF.
    Khan A; Thometz D; Garrison O; Hill JM
    Ann Allergy; 1976 May; 36(5):330-6. PubMed ID: 1084716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.